Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Plan B Rulemaking Intended To Establish Enforcement Procedures – Crawford

This article was originally published in The Tan Sheet

Executive Summary

The question of how to enforce an age-limit for OTC availability of Barr Labs' Plan B - rather than whether dual status for the drug could exist at all - was the main driver behind FDA's initiation of a rulemaking on the Rx-to-OTC switch application for the emergency contraceptive, according to former FDA Commissioner Lester Crawford
Advertisement

Related Content

Plan B Ruling Sets A Precedent That Could Give FDA Pause
Plan B Ruling Sets A Precedent That Could Give FDA Pause
Plan B Ruling Sets A Precedent That Could Give FDA Pause
Plan B Ruling Sets A Precedent That Could Give FDA Pause
Plan B Ruling Sets A Precedent That Could Give FDA Pause
FDA Depositions Reveal Crawford’s Prominent Role In Plan B Switch Review
FDA Depositions Reveal Crawford’s Prominent Role In Plan B Switch Review

Topics

Advertisement
UsernamePublicRestriction

Register

PS099484

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel